Skip to content
Screener

Climb Bio, Inc. CLYM Q2 2026 earnings

Reported August 6, 2026 · Before market open

EPS-$0.18Beat by $0.03
EPS estimate-$0.21

Next report

Nov 11, 2026 (in 2 months)
EPS estimate-$0.19

FAQ

When did Climb Bio, Inc. report Q2 2026 earnings?
Climb Bio, Inc. (CLYM) reported Q2 2026 earnings on August 6, 2026 before market open.
What were Climb Bio, Inc.'s Q2 2026 revenue and EPS?
Climb Bio, Inc. reported eps of $-0.18 for Q2 2026.
Did Climb Bio, Inc. beat estimates in Q2 2026?
EPS beat the consensus estimate of $-0.21 by $0.03.
How did Climb Bio, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 38.5% from $-0.13.
Where can I find Climb Bio, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-336762) and the 10-Q periodic report (0001193125-26-336774) directly on SEC EDGAR. The filing index links above go to sec.gov.